Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in “no …
P Jiménez-Quevedo, GV Silva, R Sanz-Ruiz… - Revista Española de …, 2008 - Elsevier
Whether stem cell treatment has the same effect in diabetics and nondiabetics is unknown.
To compare outcomes in these two groups, we analyzed data from 26 consecutive patients
with chronic ischemic cardiomyopathy who were taking part in two clinical trials.
Revascularization was not an option for these patients and they were treated with bone
marrow mononuclear cells (BMMNCs). Patients underwent NOGA electromechanical
mapping to identify viable myocardium (ie, with a unipolar voltage≥ 6.9 mV), after which …
To compare outcomes in these two groups, we analyzed data from 26 consecutive patients
with chronic ischemic cardiomyopathy who were taking part in two clinical trials.
Revascularization was not an option for these patients and they were treated with bone
marrow mononuclear cells (BMMNCs). Patients underwent NOGA electromechanical
mapping to identify viable myocardium (ie, with a unipolar voltage≥ 6.9 mV), after which …